{"@id":"https://bioecon.ru/technology/phenotype-first-ai-drug-discovery/","@type":"Technology","cluster":"bioinformatics-omics","formats":{"html":"https://bioecon.ru/technology/phenotype-first-ai-drug-discovery/","json":"https://bioecon.ru/api/v1/technology/phenotype-first-ai-drug-discovery/index.json"},"id":"phenotype-first-ai-drug-discovery","industries":["research-tools","equipment","biomanufacturing","pharma"],"lang":"ru","links":{"industries":["https://bioecon.ru/industries/research-tools/","https://bioecon.ru/industries/equipment/","https://bioecon.ru/industries/biomanufacturing/","https://bioecon.ru/industries/pharma/"],"suppliers":["https://bioecon.ru/companies/insilico-medicine/","https://bioecon.ru/companies/schr-dinger/","https://bioecon.ru/companies/tsingke-biotechnology/","https://bioecon.ru/companies/allozymes/","https://bioecon.ru/companies/rev-genomics/","https://bioecon.ru/companies/altos-labs/","https://bioecon.ru/companies/atomwise/","https://bioecon.ru/companies/hlb-genex/","https://bioecon.ru/companies/micropep-technologies/","https://bioecon.ru/companies/isomorphic-labs/","https://bioecon.ru/companies/genmab/","https://bioecon.ru/companies/turion-labs/"]},"maturity":7,"name":"ИИ-платформы разработки лекарств «фенотип-первый» с валидацией in vivo на C. elegans","regions":["ch","eu","us","cn"],"risk":"low","section":"technology","sector":"health-biomedicine","sources":[{"date":"2026-11-22","entity":"Swiss Biotech Directory 2026","kind":"vendor","urls":["https://www.swissbiotech.org/directory/"]}],"stages":[{"n":1,"title":"Генеративный ИИ-дизайн химических библиотек"},{"n":2,"title":"Высокопроизводительный скрининг на нематодах in vivo"},{"n":3,"title":"Машинное зрение для фиксации терапевтического отклика"},{"n":4,"title":"Хемопротеомная идентификация мишеней (MoA)"}],"summary":"Интегрированные платформы, совмещающие генеративный ИИ-дизайн молекул со скоростным скринингом на нематодах C. elegans in vivo.","url":"/technology/phenotype-first-ai-drug-discovery/","verified":"2026-11-22"}